They have mainly been unloading. How come?
They knew the Company not going to make Money on the Drug for this type of rare disease.
FDA approval not going to change the outcome.
That's probably it. Why they are targeting such a small niche market is beyond me. If there are no available treatment then it's understandable but there already is.